Caplan's short rendition of Stroke during the 20th century: Part II

International Journal of Stroke

Volumn 1, Issue 4, 2006, Pages 228-234

  Caplan, L R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; DICOUMAROL; FIBRINOGEN; FIBRINOLYTIC AGENT; HEPARIN; HOMOCYSTEINE; PLASMIN; STREPTOKINASE; WARFARIN;

ALCOHOL WITHDRAWAL; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOMATION; BALLOON OCCLUSION; CAROTID ARTERY; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR MALFORMATION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY THROMBOSIS; DATA BASE; DIAGNOSTIC PROCEDURE; EATING HABIT; ECHOGRAPHY; EXERCISE; GENETIC ANALYSIS; HEALTH CARE FACILITY; HEALTH PROMOTION; HEMATOCRIT; HUMAN; INCIDENCE; MEDICAL LITERATURE; MEDICAL SPECIALIST; MOLECULAR BIOLOGY; MORTALITY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSE PRACTITIONER; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; STENT; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

HISTORY, 20TH CENTURY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 33749601256     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2006.00069.x     Document Type: Article

References (95)

1. Mohr JP, Caplan LR, Melski JW et al. The Harvard Cooperative Stroke Registry: A prospective registry. Neurology 1978; 28: 754-62.
2. Foulkes MA, Wolf PA, Price TR et al. The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke 1988; 19: 547-54.
3. Bogousslavsky J, Melle GA Regli F: The Lausanne Stroke Registry: an analysis of 1000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92.
4. Moulin T, Tatu L, Crepin-Leblond T, Chavot D, Berges S, Rumbach T: The Besancon Stroke Registry: An acute stroke registry of 2500 consecutive patients. Eur Neurol 1997; 38: 10-20.
5. Chambers BR, DAnnan GA, Bladin PF: Patterns of stroke: an analysis of the first 700 consecutive admissions to the Austin Hospital Stroke Unit. Aust NZ J Med 1983; 13: 57-64.
6. Vemmos KN, Takis CE, Georgilis K et al. The Athens stroke registry: results of a five-year hospital-based study. Cerebrovasc Dis 2000; 10: 133-41.
7. Heuschmann PU, Kolominsky-Rabas PL German Stroke Registers Study Group et al. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: The German Stroke Registers Study Group. Arch Intern Med 2004; 164: 1761-68.
8. Kannel WB, Wolf PA, Verter J, McNamara PM: Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970; 214: 301-10.
9. Whisnant JP, Fitzgibbons JP, Kurland LT, Savre GP: Natural history of stroke in Rochester, Minnesotta, 1945 through 1954. Stroke 1971; 2: 11-22.
10. Oxfordshire Community Stroke Project: Incidence of stroke in Oxfordshire: First year's experience of a community stroke registry. Br Med J (Clin Res Ed) 1983; 287: 713-17.
11. White H, Boden-Albala B, Wang C et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: The Northern Manhattan Study. Circulation 2005; 111: 1327-31.
12. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K: Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. Br Med J 2006; 332: 629-35.
13. Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I: Benefit of a stroke unit: A randomized controlled trial. Stroke 1991; 22: 1026-31.
14. Indredavik B, Slordahl SA, Bakke F, Rokseth R, Haheim LL: Stroke unit treatment. Long term effects. Stroke 1997; 28: 1861-66.
15. Diez-Tejedor E, Duentes B: Acute care in stroke: do stroke units make the difference? Cerebrovasc Dis 2001; 11: 31-9.
16. Birbeck GL, Zingmond DS, Cui X, Vickrey BG: Multispecialty stroke services in California hospitals are associated with reduced mortality. Neurology 2006; 66: 1527-32.
17. Shem S: House of God. New York: Dell Publishing, 1978.
18. Stroke Unit Trialists' Collaboration: Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Br Med J 1997; 314: 1151-59.
19. Stroke Unit Trialists' Collaboration: How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 1997; 28: 2139-44.
20. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
21. Hacke W, Kaste M, Fieschi C et al., for the Second European-Australasian Acute Stroke Study Investigators: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS-ll). Lancet 1998; 352: 1245-51.
22. McLean J: The thromboplastic action of cephalin. Am J Physiol 1916; 41: 250-57.
23. Fields WS, Lemak NA: A History of Stroke. Its Recognition and Treatment. Oxford: Oxford U Press, 1989.
24. Howell WH, Holt E: Two new factors in blood coagulation-heparin and pro-antithrombin. Am J Physiol 1918; 47: 328-41.
25. Link KP: The discovcery of dicumarol and its sequels. Circulation 1959; 19: 97-107.
26. Baker RN, Broward JA, Fang HC et al. Anticoagulant therapy in cerebral infarction. Report on cooperative study. Neurology 1962; 12: 823-35.
27. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
28. Petersen P, Godtfredsen J, Boysen G et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study. Lancet 1989; 1: 175-9.
29. The Stroke prevention in Atrial Fibrillation Investigators: The stroke prevention in atrial fibrillation study: Final results. Circulation 1991; 84: 527-39.
30. EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-62.
31. Craven LL: Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Mississippi Valley Med J 1953; 75: 38-44.
32. Craven LL: Prevention of coronary and cerebral thrombosis. Mississippi Valley Med J 1956; 78: 213-5.
33. Mundall J, Quintero P, von Kaulla K et al. Transient monocular blindness and increased platelet aggregability treated with aspirin - a case report. Neurology 1971; 21: 402.
34. Harrison MJG, Marshall J, Meadows JC et al. Effect of aspirin in amaurosis fugax. Lancet 1971; 2: 743-4.
35. Fields WS, LeMak NA, Frankowski RF, Hardy RJ: Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-16.
36. The Canadian Cooperative Study Group: A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-9.
37. Fisher CM: Occlusion of the internal carotid artery. Arch Neurol Psychiatry 1951; 65: 346-77.
38. Fisher M: Occlusion of the carotid arteries. Arch Neurol Psychiatry 1954; 72: 187-204.
39. Eastcott HHG, Pickering GW, Rob CG: Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954; 2: 994-6.
40. DeBakey ME: Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen years follow-up. JAMA 1975; 233: 1083-5.
41. Carrea R, Molins M, Murphy G: Surgical treatment of spontaneous thrombosis of the internal carotid artery in the neck. Carotid-carotideal anastamosis. Acta Neurol Latinoamer 1955; 1: 71-8.
42. Cooley DA, Al-Naaman YD, Carton CA: Surgical treatment of arteriosclerotic occlusions of common carotid artery. J Neurosurg 1956; 2: 1265-7.
43. Cate WR Jr, Scott HW: Cerebral ischemia of central origin. Relief by subclavian-vertebral artery thrombendarterectomy. Surgery 1959; 45: 19-31.
44. Thompson JE: The evolution of surgery for the treatment and prevention of stroke: The Willis lecture. Stroke 1996; 27: 1427-34.
45. Estol CJ, Miller C: Fisher and the history of carotid artery disease. Stroke 1996; 27: 559-66.
46. Fields WS, North RR, Hass WK et al. Joint Study of extracranial arterial occlusion as a cause of stroke: Organization of study and survey of patient population. JAMA 1968; 203: 955-60.
47. Hass WK, Fields WS, North R et al. Joint Study of Extracranial Arterial Occlusion. II. Arteriography, techniques, sites, and complications. JAMA 1968; 203: 961-68.
48. Maroon JC, Donaghy RMP: Experimental cerebral revascularization with autogenous grafts. J Neurosurg 1973; 38: 172-79.
49. Hunter KM, Donaghy RMP: Arterial micrografts. An experimental study. Can J Surg 1973; 16: 23-7.
50. Yasargil MG, Krayenbuhl HA, Jacobson JH: Microneurosurgical arterial reconstruction. Surgery 1970; 67: 221-33.
51. Yasargil MG (ed): Microsurgery Applied to Neurosurgery. Stuttgart: George Thieme Verlag, 1969.
52. EC/IC Bypass Study Group: Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. N Engl J Med 1985; 313: 191-200.
53. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators: Beneficial effects of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-53.
54. Barnett HJM, Taylor DW, Eliasziw M et al., for the North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339: 1415-25.
55. European Carotid Surgery Trialists' Collaborative Group: MRC European Carotid Surgery trial: Interim results of symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-43.
56. European Carotid Surgery Trialists' Collaborative Group: Randomized trial of endarterectomy for recently symptomatic carotid stnosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-87.
57. Asymptomatic Carotid Atherosclerosis Study Group: Carotid endarterectomy for patients with asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-28.
58. Halliday AW, Thomas DJ, Mansfield AO: The asymptomatic carotid surgery trial (ACST). Int Angiol 1995; 14: 18-20.
59. Halliday A, Mansfield A, Marro J: Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004; 363: 1491-502.
60. Meinert CL: Clinical Trials: Design, Conduct, and Analysis. New York: Oxford University Press, 1986.
61. Sackett DL: EvidencW-based medicine: what it is and what it isn't. Br Med J 1996; 312: 71-2.
62. Sackett DL, Rosenberg W: On the need for evidence-based medicine. J Public Health Med 1995; 88: 620-4.
63. Caplan LR: Editorial EvidenceCbased medicine: concerns of a clinical neurologist. J Neurology Neurosurg Psychiatry 2001; 71: 569-76.
64. Sloan MA: ThrombolyPis and stroke: past and future. Arch Neurol 1987; 44: 748-68.
65. Sussman BJ, Fitch TSP: Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 1958; 167: 1705-9.
66. Herndon RM, Meyer JS, Johnson JF et al. Treatment of cardiovascular thrombosis with fibrinolysisn. Am J Cardiol 1960; 30: 540-45.
67. Clark RL, Clifton EE: The treatment of cerebrvascular thrombosis and embolism with fibrinolytic agents. Am J Cardiol 1960; 30: 546-51.
68. Meyer JS, Gilroy J, Barnhart ME et al. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA 1963; 189: 373.
69. Meyer JS, Gilroy J, Barnhart ME et al. Therapeutic thrombolysis in cerebral thromboembolism. Randomized evaluation of intravenous streptokinase; in Millikan CH, Siekert R, Whisnant JP (eds): Cerebral Vascular Diseases. New York: Grune & Sratton, 1964: 200-13.
70. Zeumer H, Hacke W, Ringelstein EB: Intra-arterial thrombolysis in vertebrobasilar thromboembolic disease. Am J Neuroradiol 1983; 4: 401-4.
71. Zeumer H, Hundgen R, ferbert A et al. Local intra-arterial fibrinolyic therapy in inaccessible internal carotid occlusion. Neuroradiology 1984; 76: 315-7.
72. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo G: Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19: 1216-22.
73. del Zoppo GJ, Poeck K, Pessin MS et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78-86.
74. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, Del Zoppo GT. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Am J Neuroradiol 1993; 14: 3-13.
75. Pessin MS, del Zoppo GJ, Furlan AJ: Thrombolytic treatment in acute stroke: Review and update of selected topics; in Cerebrovascular Diseases, 19 th Princeton Conference, 1994. Boston: Butterworth-Heinemann, 1995: 409-18.
76. Hacke W, del Zoppo GJ, Hirschberg M (eds): Thrombolytic Therapy in Acute Ischemic Stroke. Berlin: Springer-Verlag, 1991.
77. The National Institute of Neurological Disorders and Stroke rt-PA Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-87.
78. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
79. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS ll). Lancet 1998; 352: 1245-51.
80. Adams HP, Brott TG, Furlan AJ et al. Use of thrombolytic drugs. A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for Health Care Professionals from a special writing group of the Stroke Council American Heart Association. Stroke 1996; 27: 1711-8.
81. Quality Standards Subcommittee of the American Academy of Neurology, Practice Advisory: Thrombolytic therapy for acute ischemic stroke- summary statement. Neurology 1996; 47: 835-9.
82. del Zoppo GJ, Higashida RT, Furlan AJ et al. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29: 4-11.
83. Furlan AJ, Higashida RT, Wechsler L et al. Intra-arterial Prourokinase for acute ischemic stroke. The Proact ll Study: A randomized controlled trial. JAMA 1999; 282: 2003-11.
84. Serbenenko FA: Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg 1974; 41: 125-45.
85. Introcaso JH, Uske A: Endovascular treatment of intracranial aneurysms; in Batjer HH, Caplan LR, Friberg L, Greenlee RG Jr, Kopitnik TA Jr, Young WL (eds): Cerebrovascular Disease. Philadelphia, PA: Lippincott-Raven, 1996: 915-27.
86. Guglielmi G, Vinuela F, Sepetka I et al. Electrothrombosis of saccular aneurysms. Neurosurgery via endovascular approach. L. Electrochemical basis, technique, and experimental results. J Neurosurg 1991; 75: 1-7.
87. Latchaw RE, Madison MT, Larsen DW, Silva P: Intracranial arteriovenous Malformations: Endovascular strategies and methods; in Batjer HH, Caplan LR, Friberg L, Greenlee RG Jr, Kopitnik TA Jr, Young WL (eds): Cerebrovascular Disease. Philadelphia, PA: Lippincott-Raven, 1996: 707-25.
88. Luessenhop AJ, Spence WT: Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation. JAMA 1960; 172: 1153-5.
89. Gruentzig A: Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263.
90. Gruentzig AR, Senning A, Siegenthaler WE: Nonoperative dilatation of coronary aretery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-8.
91. Meyers PM, Schumacher HC, Higashida RT, Leary MC, Caplan LR: Use of stents to treat extracranial cerebrovascular disease. Ann Rev Med 2006; 57: 437-54.
92. Kerber CW, Cromwell LD, Loehden OL: Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. Am J Neuroradiol 1980; 1: 348-9.
93. Bockenheimer SA, Mathias K: Percutaneous transluminal angioplasty in arteriosclerotic internal carotid artery stenosis. Am J Neuroradiol 1983; 4: 791-2.
94. Theron J, Raymond J, Casasco A, Courtheoux F: Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol 1987; 8: 495-500.
95. Kachel R: Results of balloon angioplasty in the carotid arteries. J Endovasc Surg 1996; 3: 22-30.